Millennium Management’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
924,772
+429,335
| +87% | +$1.46M | ﹤0.01% | 2380 |
|
|
2025
Q1 | $1.99M | Sell |
495,437
-308,486
| -38% | -$1.24M | ﹤0.01% | 2601 |
|
|
2024
Q4 | $5.22M | Buy |
803,923
+613,314
| +322% | +$3.98M | ﹤0.01% | 1972 |
|
|
2024
Q3 | $1.06M | Sell |
190,609
-755,881
| -80% | -$4.19M | ﹤0.01% | 2895 |
|
|
2024
Q2 | $5.28M | Buy |
946,490
+919,845
| +3,452% | +$5.13M | ﹤0.01% | 1890 |
|
|
2024
Q1 | $179K | Buy |
+26,645
| New | +$179K | ﹤0.01% | 3693 |
|
|
2023
Q4 | – | Sell |
-427,954
| Closed | -$2.36M | – | 4170 |
|
|
2023
Q3 | $2.36M | Sell |
427,954
-152,049
| -26% | -$839K | ﹤0.01% | 2373 |
|
|
2023
Q2 | $4.95M | Sell |
580,003
-372,172
| -39% | -$3.18M | ﹤0.01% | 1947 |
|
|
2023
Q1 | $8.75M | Buy |
952,175
+817,445
| +607% | +$7.51M | 0.01% | 1537 |
|
|
2022
Q4 | $1.38M | Sell |
134,730
-273,729
| -67% | -$2.8M | ﹤0.01% | 2930 |
|
|
2022
Q3 | $6.01M | Sell |
408,459
-494,023
| -55% | -$7.27M | ﹤0.01% | 2045 |
|
|
2022
Q2 | $9.68M | Buy |
902,482
+784,708
| +666% | +$8.42M | 0.01% | 1548 |
|
|
2022
Q1 | $1.27M | Buy |
+117,774
| New | +$1.27M | ﹤0.01% | 3414 |
|
|
2021
Q4 | – | Sell |
-178,978
| Closed | -$3.83M | – | 5249 |
|
|
2021
Q3 | $3.83M | Buy |
+178,978
| New | +$3.83M | ﹤0.01% | 2449 |
|